Assessing the reliability of intestinal ultrasound in Crohn's disease
Official title: Reliability of IUS in Crohn's Disease
Run by Centre Hospitalier Universitaire, Amiens · NCT06833450 · Data updated 2026-11-12
This study is testing if a special ultrasound can help doctors check how active Crohn's disease is in patients and see if different doctors agree on the results.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Status | Recruiting |
| Started | January 19, 2022 |
| Main results expected | February 2026 |
| Study ends | February 2026 |
| Registry record updated | February 18, 2025 |
| Trial ID | NCT06833450 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with a diagnosis of Crohn's disease for at least one month.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or minors will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the reliability of transabdominal intestinal ultrasound (IUS) as a point-of-care test for assessing disease activity in patients with Crohn's disease. It aims to establish inter-observer agreement on various parameters related to the disease, which will help in defining transmural healing and applying IUS consistently in treatment outcome assessments. By doing so, the study seeks to ensure comparability between future studies involving Crohn's disease.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of monitoring disease activity in Crohn's disease, leading to better treatment outcomes for patients.
How similar studies have gone: Other studies have shown promise in using intestinal ultrasound for assessing Crohn's disease, indicating that this approach is gaining acceptance in the medical community.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Crohn's disease evolving for at least 1 months * Patient older than 18 years * Patient covered by French national health insurance * Written informed consent Exclusion Criteria: * Pregnant women or breastfeeding * Minor * Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)
Where it's running
-
CHU d'Amiens
Amiens, France Recruiting
Study contacts
- Study coordinator: Mathurin Fumery, Pr
- Email: Fumery.mathurin@chu-amiens.fr
- Phone: 33+3 22 08 88 40
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reduce ultra-processed foods to help kids with Crohn's stay in remission longer
This study tests whether and how reducing ultra-processed foods with dietitian guidance helps children and teens with Crohn's disease stay in remission longer.
-
Endoscopic stricturotomy vs balloon dilation for small bowel Crohn’s stricture
This trial tests whether endoscopic stricturotomy can be safely and effectively used to treat small bowel fibrotic strictures in Crohn’s disease, compared with endoscopic balloon dilation.
-
Prediction of postoperative recurrence in Crohn's disease after surgery
A multicenter study will test a multimodal model to predict which Crohn's patients are likely to have disease recur after intestinal resection.
-
Perianal fistula imaging comparison using TPUS, MRI, EUS, and EUA
This study tests how well four imaging methods—transperineal ultrasound, MRI, endoscopic ultrasound, and examination under anesthesia—detect and describe perianal fistulas in adults with Crohn's disease or unknown cause.
-
Familial IBD Early Risk
This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.
-
Impact of sucralose on gut health in Crohn's disease
This study tests whether the non-nutritive sweetener sucralose changes gut bacteria in adults with Crohn's disease compared to healthy controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.